Shares in the company begin trading on the Nasdaq and Easdaq exchanges. The IHD will collect healthcare data from anonymized patient records from the Icelandic healthcare system, and deCODE plans to use the database to support its disease-gene research and to develop healthcare informatics and privacy protection products. In January the number of employees has reached 300. The company's researchers map a novel gene that contributes to the occurrence of the most common form of Alzheimer's disease . Scientists at deCODE succesfully map a gene associated with stroke .
Icelandic investors acquire a large stake in the company.